汉密顿抑郁量表

  • 网络hamd;HRSD
汉密顿抑郁量表汉密顿抑郁量表
  1. 结果两组治疗后各周汉密顿抑郁量表评分均较治疗前显著下降(P<0.01);

    Results Compared with pretreatment , scores of the HAMD in each week during treatment significantly decreased for both groups ( P < 0.01 );

  2. 以汉密顿抑郁量表(HAMD)评价抑郁症状变化,以副反应症状量表(TESS)评定副反应。

    Changes of depressive symptoms and side reactions were assessed with the HAMD and TESS respectively .

  3. 用汉密顿抑郁量表(HAMD)、不良反应量表(TESS)分别评定疗效和不良反应。

    The efficacy was assessed by Hamilton Depression Rating Scale ( HAMD ) .

  4. 结果治疗第1w末,汉密顿抑郁量表评分较治疗前减少,差异有显著性;

    Results The score of HAMD decreased significantly at the end of1 week posttreatment .

  5. 方法对停用精神药物3d的18例病人估价其汉密顿抑郁量表(HAMD)总分/诸因子分与14项睡眠脑电图参数的相关性。

    Method It was estimated correlations between HAMD total score / various factor scores and 14 parameters of sleep EEG in 18 patients with depression no taking psychotropics for 3 days .

  6. 方法:采用一般情况问卷、抑郁自评量表(SDS)和汉密顿抑郁量表(HAMD)对不同性别首发抑郁症患者进行测查。

    Method : Adopt self rating depression scale ( SDS ) and Hamilton depression rating scale ( HAMD ) to test difference gender patients with depression .

  7. 结果偏执型精神分裂症、多次住院、年龄较小、受教育的时间较少者易出现抑郁症状。治疗后汉密顿抑郁量表总分与一般精神病理量表、抑郁症状群、TESS正相关。

    Results : The patients who were young , with the diagnosis of paranoid schizophrenia , had more admission times and less education had more risks to suffer from depression .

  8. 应用Beck抑郁自评量表(BDI)、汉密顿抑郁量表(HAMD)对两组治疗前、治疗2周、4周、8周(治疗结束)时的疗效进行评定;

    Assessments of the efficacy were performed with Beck depression inventory ( BDI ) and Hamilton depression scale ( HAMD ) before and in the 2nd , 4th , 8th week during treatment .

  9. 以自知力与治疗态度问卷(ITAQ)和汉密顿抑郁量表(HAMD)进行评定,观察两组自知力恢复情况及服药依从性变化。

    Insight treatment attitude questionnaire ( ITAQ ) and Hamilton depressive scale ( HAMD ) were used to assess the recovery of insight and changes in compliance .

  10. 于治疗前及治疗4周末,采用汉密顿抑郁量表(HAMD)、事件相关电位P300进行临床病情评估,评定临床疗效及患者认知功能改善情况。

    Clinical efficacy and the improvement of cognitive function were assessed with the Hamilton Depression Scale ( HAMD ) and the event related potentials ( ERPs ) P300 before treatment and at the end of the 4th week treatment .

  11. 与治疗前和治疗2w,4w,6w,8w末采用汉密顿抑郁量表评定临床疗效,副反应量表评定不良反应,并进行比较分析。

    Curative effects were assessed with the HAMD and adverse reactions with the TESS before treatment and at the ends of the 2nd , 4th , 6th and 8th week treatment .

  12. 方法38例难治性抑郁症患者在合并利培酮治疗前及治疗后4周末分别检测患者外周血血小板5-HT浓度,并评估汉密顿抑郁量表17项(HAMD17)、汉密顿焦虑量表(HAMA)。

    Methods : Before and 4 weeks after risperidone was added , the serotonin concentrations were measured and Hamilton Depression Scale ( HAMD ) and Hamilton Anxiety Scale ( HAMA ) scores were rated for the 38 treatment-resistant depression patients .

  13. 目的检验汉密顿抑郁量表6项版本(HAMD-6)的信度与效度。

    Objective To explore the validity and reliability of the 6-item Hamilton Depression Rating Scale ( HAMD-6 ) .

  14. 另应用银屑病皮损面积和严重程度指数(PASI)计算皮损得分和汉密顿抑郁量表(HAMD)计算病人抑郁情绪得分。

    Secondly , apply Psoriasis assessment and severity index ( PASI ) and Hamilton Depression Scale ( HAMD ) to measure the changes of the scores of psoriatic lesions and the changes of depressive mood on patients , respectively .

  15. 方法:于2002-10/2003-12选取首都医科大学附属北京安定医院老年科住院及门诊符合ICD-10诊断标准的老年抑郁症患者48例为观察对象,汉密顿抑郁量表(17项)评分≥18分。

    METHODS : Forty-eight elderly inpatients or outpatients with depression from October 2002 to December 2003 , who met the ICD-10 criteria geriatric depression with the HAMD-17 score ≥ 18 points , were selected from Beijing Anding Hospital Affiliated to Capital Medical University .

  16. 方法采用糖尿病患者特异性生活质量量表(DSQL)、汉密顿抑郁量表(HRSD)、汉密顿焦虑量表(HAMA)对58例糖尿病住院患者进行调查。

    Methods 58 diabetic cases were investigated by Special of Quality of Life for Diabetes Mellitus ( DSQL ), Hamilton Depression Rating Scale for Depression ( HRSD ), Hamilton Anxiety Rating Scale for Anxiety ( HAMA ) .

  17. 采用视觉模拟评分法(VAS)、SF-MPQ评分疼痛积分、汉密顿抑郁量表、综合疗效评分等为疗效指标,治疗前和每一个疗程治疗后,记录各项评分。

    We are Use the visual analogue scale ( VAS ), SF-MPQ score pain points , Hamilton Depression Scale score as the integrated effect of therapeutic index , test before and after each course of treatment , and then record the scores .

  18. 结果两组治疗1w、2w末汉密顿抑郁量表评分均较治疗前显著下降(P<0.05或0.01),研究组较对照组下降显著(P<0.01或0.05);

    Results Compared with pretreatment , at the ends of the 1st and 2nd week the HAMD scores of both 2 groups descended significantly ( P < 0.05 or 0.01 ), and decrease was more significant in the research group than in the control ( P < 0.01 or 0.05 );

  19. 12w末研究组汉密顿抑郁量表评分较对照组下降显著(P<0.05),副反应量表评分差异无显著性(P>0.05)。

    At the end of 12th week , score of the HAMD decreased more significantly in the research than in the control group ( P < 0.05 ), and there was no difference in the TESS between the 2 groups ( P > 0.05 ) .

  20. 方法采用汉密顿抑郁量表对70例脑中风患者进行测查。

    Methods 70 cases of cerebral stroke patient were detected with Hamilton table .

  21. 汉密顿抑郁量表的因素结构研究

    Factorial structure of the Hamilton Depression Scale in the Chinese patients with depressive disorder

  22. 所有的病人的汉密顿抑郁量表的得分都在20分以上。

    All the patients had a Hamilton Depression Rating Scale score of20 or above .

  23. 汉密顿抑郁量表分数的降低支持了临床治疗,平均差别在2.26个百分点。

    The average reduction in HAM-D scores favored clinical management , at an average difference of2.26 points .

  24. 目的探索和检验汉密顿抑郁量表在中国抑郁障碍人群中的因素结构。

    ObjectiveTo examine the factorial structure of the Hamilton Depression Scale ( HAMD ) in a sample of Chinese depressive patients .

  25. 目的:探讨脑卒中患者病变部位与汉密顿抑郁量表评分的关系。

    AIM : To investigate the relationship between the lesion sites and the score of Hamilton depressive scale in patients with stroke .

  26. 治疗前、治疗后1、2、4、8、12周及6个月分别采用汉密顿抑郁量表评定患者的抑郁症状。

    Neurological function impairment and ADL before treatment and at 1st , 2nd , 4th , 8th , 12th week and 6th month after the treatment .

  27. 抑郁情绪评定采用汉密顿抑郁量表,内容:躯体化(包括精神性焦虑、躯体性焦虑、胃肠道症状、疑病和自知力);

    Depression emotion was evaluated with Hamilton Depression Rating Scale , consisted of somatization ( psycho-anxiety , somatic anxiety , gastrointestinal tract symptom , hypochondriasis and insight );

  28. 结果:万拉法新治疗前后汉密顿抑郁量表评分分别为26.18±6.56,10.66±7.39(P<0.01);

    Results : The scores rated for the patients before and after Venlafaxine therapy was 26.18 ± 6.56 and 10.66 ± 7.39 , respectively , being statistically different ( P < 0.01 ) .

  29. 采用汉密顿抑郁量表及汉密顿焦虑量表评定临床疗效,副作用量表评定不良反应。

    The efficacies were assessed with the Hamilton Depression Scale ( HAMD ) and the Hamilton Anxiety Scale ( HAMA ) and adverse reactions with the Treatment Emer-gent Symptom Scale ( TESS ) .

  30. 于入组时评定汉密顿抑郁量表,总分≥24分为重型抑郁症,总分<24分为轻型抑郁症。

    When entering the groups , all the subjects were assessed with Hamilton depression scale , the total score of ≥ 24 points was taken as severe depression and < 24 points as mild depression .